RIG
GBT

Roosevelt Investment Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Roosevelt Investment Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10M Sell
146,845
-655,545
-82% -$36.2M 0.72% 45
2022
Q2 		$25.6M Buy
802,390
+205,543
+34% +$6.02M 1.84% 13
2022
Q1 		$20.7M Buy
596,847
+180,182
+43% +$5.39M 1.23% 34
2021
Q4 		$12.2M Buy
+416,665
New +$12.9M 0.68% 46

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Roosevelt Investment Group's GBT Position: Q3 2022 in Review

Roosevelt Investment Group reduced its Global Blood Therapeutics, Inc. (GBT) stake by 82% in Q3 2022, selling an estimated $36.2M and leaving 146,845 shares worth $10M. The position accounts for 0.72% of the portfolio, ranked #45.

Roosevelt Investment Group first reported a position in GBT in Q4 2021 and has held it in 4 quarters since. The position peaked at $25.6M in Q2 2022. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Roosevelt Investment Group held 146,845 shares of Global Blood Therapeutics, Inc. worth $10M as of Q3 2022.
  • Roosevelt Investment Group sold 655,545 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $36.2M.
  • Global Blood Therapeutics, Inc. made up 0.72% of Roosevelt Investment Group's portfolio in Q3 2022, its #45 holding.
  • Roosevelt Investment Group first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and has held it in 4 quarters since.
  • Roosevelt Investment Group's Global Blood Therapeutics, Inc. position peaked at $25.6M in Q2 2022.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Roosevelt Investment Group's 13F filing for Q3 2022, filed 19 Oct 2022.